Log in

NASDAQ:TRVITrevi Therapeutics Institutional Ownership

-0.63 (-8.28 %)
(As of 07/6/2020 04:00 PM ET)
Today's Range
Now: $6.98
50-Day Range
MA: $4.54
52-Week Range
Now: $6.98
Volume139,300 shs
Average Volume73,476 shs
Market Capitalization$124.55 million
P/E RatioN/A
Dividend YieldN/A

Institutional Ownership

Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)

Institutional Ownership Percentage: 78.32%

Institutional Buying and Selling by Quarter

Trevi Therapeutics (NASDAQ TRVI) Institutional Buying and Selling

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
5/15/2020Driehaus Capital Management LLC117,371$0.39M0.0%-6.1%0.658%
3/11/2020Franklin Resources Inc.587,347$2.20M0.0%-16.1%3.293%
2/12/2020Franklin Resources Inc.587,347$2.20M0.0%-16.1%3.294%
11/27/2019Stifel Financial Corp24,565$0.11M0.0%N/A0.138%
10/11/2019NEA Management Company LLC4,441,360$19.99M1.7%+0.3%24.909%
8/14/2019Morgan Stanley5,659$42K0.0%N/A0.032%
8/14/2019Vanguard Group Inc.118,091$0.89M0.0%N/A0.662%
8/13/2019BlackRock Inc.3,484$26K0.0%N/A0.020%
8/13/2019Omega Fund Management LLC1,263,408$9.48M2.4%N/A7.086%
8/13/2019Northern Trust Corp16,480$0.12M0.0%N/A0.092%
(Data available from 1/1/2016 forward)
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.